Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Summit Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2025 | 3 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2026 | 2 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2026 | 2 | -$0.15 | -$0.15 | -$0.15 |
Summit Therapeutics Inc. Earnings Date And Information
Summit Therapeutics Inc. last posted its earnings results on Monday, February 24th, 2025. The company reported $-0.08 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08181 by $0.00181. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Summit Therapeutics Inc. has generated $0 earnings per share over the last year ($-0.31 diluted earnings per share) and currently has a price-to-earnings ratio of -66.8. Summit Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based on prior year's report dates.
Summit Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/24/2025 | Q4 2024 | -$0.08 | -$0.08 | -0 | $0 | $0 |
| 10/30/2024 | Q3 2024 | -$0.07 | -$0.08 | -0.01 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.06 | -$0.09 | -0.03 | $0 | $0 |
| 05/01/2024 | Q1 2024 | -$0.06 | -$0.06 | -0 | N/A | $0 |
| 02/20/2024 | Q4 2023 | N/A | -$0.05 | N/A | $9.74 M | $-235,000 |
| 11/07/2023 | Q3 2023 | N/A | -$0.03 | N/A | N/A | $0 |
| 08/09/2023 | Q2 2023 | N/A | -$0.02 | N/A | N/A | $235,000 |
| 05/11/2023 | Q1 2023 | N/A | -$1.43 | N/A | N/A | $0 |
| 03/09/2023 | Q4 2022 | -$0.26 | -$0.08 | 0.18 | N/A | $705 |
| 11/09/2022 | Q3 2022 | -$0.26 | -$0.17 | 0.09 | N/A | $220,000 |
| 08/11/2022 | Q2 2022 | -$0.27 | -$0.12 | 0.15 | N/A | $235,000 |
| 05/11/2022 | Q1 2022 | -$0.28 | -$0.21 | 0.07 | N/A | $250,000 |
| 03/17/2022 | Q4 2021 | -$0.27 | -$0.28 | -0.01 | N/A | $251,000 |
| 11/15/2021 | Q3 2021 | -$0.29 | -$0.20 | 0.09 | N/A | $1.31 M |
| 08/12/2021 | Q2 2021 | N/A | -$0.27 | N/A | $3.22 M | $57,000 |
| 05/17/2021 | Q1 2021 | N/A | -$0.21 | N/A | $3.19 M | $192,000 |
| 03/31/2021 | Q4 2020 | N/A | -$0.18 | N/A | $2.90 M | $185,000 |
| 11/16/2020 | Q3 2020 | -$0.01 | -$0.26 | -0.25 | $3.16 M | $181,000 |
| 06/30/2020 | Q2 2020 | N/A | -$0.23 | N/A | $3.21 M | $170,000 |
| 03/31/2020 | Q1 2020 | N/A | -$0.11 | N/A | $4.22 M | $386,291 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc. Earnings: FAQ's
Summit Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based offlast year's report dates.
In the previous quarter, Summit Therapeutics Inc. (:SMMT) reported $-0.08 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08181 by $0.00181.
The conference call for Summit Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Summit Therapeutics Inc.'s latest earnings report can be read online.
Summit Therapeutics Inc. (:SMMT) has a recorded net income of $-221,315,000.Summit Therapeutics Inc. has generated $-0.31 earnings per share over the last four quarters.
Summit Therapeutics Inc. (:SMMT) has a price-to-earnings ratio of -66.8 and price/earnings-to-growth ratio is 6.23.